{"transactions":[{"id":917713,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":1,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":2,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":3,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":4,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44676,"kind":"person","name":"Alex Slanix Paul","position":5,"cik":"0002092283","reported_name":"Alex Slanix Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2026-02-06T00:00:01.000Z","date":"2026-02-03","kind":"purchase","planned":false,"acquired":true,"shares":700741,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Warrants were purchased together with the Common Shares reported herein for an aggregate purchase price of $12.13 per Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The warrants to purchase Common Shares (the \"Warrants\") are exercisable immediately and will expire upon the earlier of (i) within 60 days of the Milestone Event or (ii) February 3, 2031. For purposes of the foregoing, the \"Milestone Event\" means the public announcement via press release or the filing of a Current Report on Form 8-K by the Issuer of topline data from the cohorts treated with single ascending doses of PMN310."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The warrants to purchase Common Shares (the \"Warrants\") are exercisable immediately and will expire upon the earlier of (i) within 60 days of the Milestone Event or (ii) February 3, 2031. For purposes of the foregoing, the \"Milestone Event\" means the public announcement via press release or the filing of a Current Report on Form 8-K by the Issuer of topline data from the cohorts treated with single ascending doses of PMN310."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Fan Yu is the controlling stockholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC, which manages the investments of Ally Bridge MedAlpha Master Fund L.P. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the securities held of record by Ally Bridge MedAlpha Master Fund L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Fan Yu is also the indirect controlling stockholder of ABG Global Life Science Capital Partners V GP Limited, which is the general partner of ABG Global Life Science Capital Partners V GP, L.P., which is the general partner of Ally Bridge Group Global Life Science Capital Partners V, L.P., which is the controlling shareholder of ABG V-SIV IX Limited. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the securities held of record by ABG V-SIV IX Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Fan Yu is also the controlling stockholder of ABG V-SIV X Limited. As such, Mr. Fan Yu may be deemed to share beneficial ownership of the securities held of record by ABG V-SIV X Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The Warrants reported herein include: (i) Warrants to purchase 164,881 Common Shares held of record by Ally Bridge MedAlpha Master Fund L.P., (ii) Warrants to purchase 329,760 Common Shares held of record by ABG V-SIV IX Limited and (iii) Warrants to purchase 206,100 Common Shares held of record by ABG V-SIV X Limited."}],"balance_after":700741,"derivative":{"exercise_price":14.4,"underlying":"Common Shares","underlying_shares":700741},"source":{"system":"sec-edgar","filing":"0001493152-26-005410","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668029/000149315226005410/ownership.xml","form_type":"4"}},{"id":917712,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":1,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":2,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":3,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":4,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44676,"kind":"person","name":"Alex Slanix Paul","position":5,"cik":"0002092283","reported_name":"Alex Slanix Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-02-06T00:00:01.000Z","date":"2026-02-03","kind":"purchase","planned":false,"acquired":true,"shares":700741,"price":12.13,"value":8499988.33,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Warrants were purchased together with the Common Shares reported herein for an aggregate purchase price of $12.13 per Common Share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Common Shares reported herein include: (i) 407,230 Common Shares held of record by Ally Bridge MedAlpha Master Fund L.P., (ii) 329,760 Common Shares held of record by ABG V-SIV IX Limited and (iii) 206,100 Common Shares held of record by ABG V-SIV X Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Fan Yu is the controlling stockholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC, which manages the investments of Ally Bridge MedAlpha Master Fund L.P. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the securities held of record by Ally Bridge MedAlpha Master Fund L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Fan Yu is also the indirect controlling stockholder of ABG Global Life Science Capital Partners V GP Limited, which is the general partner of ABG Global Life Science Capital Partners V GP, L.P., which is the general partner of Ally Bridge Group Global Life Science Capital Partners V, L.P., which is the controlling shareholder of ABG V-SIV IX Limited. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the securities held of record by ABG V-SIV IX Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Fan Yu is also the controlling stockholder of ABG V-SIV X Limited. As such, Mr. Fan Yu may be deemed to share beneficial ownership of the securities held of record by ABG V-SIV X Limited."}],"balance_after":943090,"source":{"system":"sec-edgar","filing":"0001493152-26-005410","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668029/000149315226005410/ownership.xml","form_type":"4"}},{"id":1013832,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":1,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":2,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":3,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":4,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44676,"kind":"person","name":"Alex Slanix Paul","position":5,"cik":"0002092283","reported_name":"Alex Slanix Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2025-10-24T20:34:08.000Z","date":"2025-10-22","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option vested on the date of grant and the remaining shares shall vest in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This option was granted to Slanix Alex, a director of the Issuer and an employee of Ally Bridge Group (NY) LLC, which manages the investments of Ally Bridge MedAlpha Master Fund L.P. Dr. Alex holds any equity-based compensation awarded to him for his service as a director of the Issuer for the benefit of Ally Bridge MedAlpha Master Fund L.P. Any proceeds from the sale of shares upon exercise of this award shall be remitted to Ally Bridge MedAlpha Master Fund L.P. The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such securities are beneficially owned by him for Section 16 or any other purpose."}],"balance_after":40000,"derivative":{"exercise_price":0.45,"expiration_date":"2035-10-22","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-25-019320","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668029/000149315225019320/ownership.xml","form_type":"4"}},{"id":1847938,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Warrant (Right to Buy)","published_at":"2023-06-21T16:05:12.000Z","date":"2023-06-16","kind":"other","planned":false,"acquired":true,"shares":965130,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 13, 2023, pursuant to the securities purchase agreement, dated as of March 9, 2023 (the \"2023 Securities Purchase Agreement\"), by and among the Issuer and the certain purchasers listed therein, ABG WTT-MedAvail Limited (\"ABG WTT\") and Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\") purchased from the Issuer 6,818,181 and 965,130 Pre-Funded Warrants, respectively, at a purchase price of $0.3212 per share. Pursuant to the 2023 Securities Purchase Agreement, ABG WTT and MedAlpha also purchased for no additional consideration 6,818,181 and 965,130 Series A Warrants, respectively. The Series A Warrants were issued two business days following the date the Issuer received required approval of the Issuer's stockholders on June 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 13, 2023, pursuant to the securities purchase agreement, dated as of March 9, 2023 (the \"2023 Securities Purchase Agreement\"), by and among the Issuer and the certain purchasers listed therein, ABG WTT-MedAvail Limited (\"ABG WTT\") and Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\") purchased from the Issuer 6,818,181 and 965,130 Pre-Funded Warrants, respectively, at a purchase price of $0.3212 per share. Pursuant to the 2023 Securities Purchase Agreement, ABG WTT and MedAlpha also purchased for no additional consideration 6,818,181 and 965,130 Series A Warrants, respectively. The Series A Warrants were issued two business days following the date the Issuer received required approval of the Issuer's stockholders on June 14, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by MedAlpha. Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC, which manages MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":965130,"derivative":{"exercise_price":0.3854,"exercise_date":"2023-06-16","expiration_date":"2028-06-16","underlying":"Common Stock","underlying_shares":965130},"source":{"system":"sec-edgar","filing":"0000899243-23-016125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924323016125/doc4.xml","form_type":"4"}},{"id":1847937,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Warrant (Right to Buy)","published_at":"2023-06-21T16:05:12.000Z","date":"2023-06-16","kind":"other","planned":false,"acquired":true,"shares":6818181,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 13, 2023, pursuant to the securities purchase agreement, dated as of March 9, 2023 (the \"2023 Securities Purchase Agreement\"), by and among the Issuer and the certain purchasers listed therein, ABG WTT-MedAvail Limited (\"ABG WTT\") and Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\") purchased from the Issuer 6,818,181 and 965,130 Pre-Funded Warrants, respectively, at a purchase price of $0.3212 per share. Pursuant to the 2023 Securities Purchase Agreement, ABG WTT and MedAlpha also purchased for no additional consideration 6,818,181 and 965,130 Series A Warrants, respectively. The Series A Warrants were issued two business days following the date the Issuer received required approval of the Issuer's stockholders on June 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 13, 2023, pursuant to the securities purchase agreement, dated as of March 9, 2023 (the \"2023 Securities Purchase Agreement\"), by and among the Issuer and the certain purchasers listed therein, ABG WTT-MedAvail Limited (\"ABG WTT\") and Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\") purchased from the Issuer 6,818,181 and 965,130 Pre-Funded Warrants, respectively, at a purchase price of $0.3212 per share. Pursuant to the 2023 Securities Purchase Agreement, ABG WTT and MedAlpha also purchased for no additional consideration 6,818,181 and 965,130 Series A Warrants, respectively. The Series A Warrants were issued two business days following the date the Issuer received required approval of the Issuer's stockholders on June 14, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT. ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":6818181,"derivative":{"exercise_price":0.3854,"exercise_date":"2023-06-16","expiration_date":"2028-06-16","underlying":"Common Stock","underlying_shares":6818181},"source":{"system":"sec-edgar","filing":"0000899243-23-016125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924323016125/doc4.xml","form_type":"4"}},{"id":1952323,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrant (Right to Buy)","published_at":"2023-03-15T16:30:12.000Z","date":"2023-03-13","kind":"purchase","acquired":true,"shares":965130,"price":0.3212,"value":309999.756,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Prior to the Issuer receiving certain required approval of the Issuer's stockholders (the \"Requisite Stockholder Approval\"), the Pre-Funded Warrant holders may only exercise up to the product of (i) the holder's pro rata portion of the Pre-Funded Warrants and (ii) 16,025,925, which is the number of shares equal to 19.99% of the Issuer's Common Stock outstanding on March 9, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Pre-Funded Warrants do not expire."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC, which manages MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":965130,"derivative":{"exercise_price":0.001,"exercise_date":"2023-03-13","underlying":"Common Stock","underlying_shares":965130},"source":{"system":"sec-edgar","filing":"0000899243-23-008565","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924323008565/doc4.xml","form_type":"4"}},{"id":1952322,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrant (Right to Buy)","published_at":"2023-03-15T16:30:12.000Z","date":"2023-03-13","kind":"purchase","acquired":true,"shares":6818181,"price":0.3212,"value":2189999.7372,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Prior to the Issuer receiving certain required approval of the Issuer's stockholders (the \"Requisite Stockholder Approval\"), the Pre-Funded Warrant holders may only exercise up to the product of (i) the holder's pro rata portion of the Pre-Funded Warrants and (ii) 16,025,925, which is the number of shares equal to 19.99% of the Issuer's Common Stock outstanding on March 9, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Pre-Funded Warrants do not expire."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":6818181,"derivative":{"exercise_price":0.001,"exercise_date":"2023-03-13","underlying":"Common Stock","underlying_shares":6818181},"source":{"system":"sec-edgar","filing":"0000899243-23-008565","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924323008565/doc4.xml","form_type":"4"}},{"id":1973548,"issuer":{"id":115963,"kind":"organization","name":"ABG Acquisition Corp. I","symbol":"ABGI"},"owners":[{"id":67587,"kind":"person","name":"Yu Fan","position":1,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B ordinary shares","published_at":"2023-03-03T21:00:27.000Z","date":"2023-03-01","kind":"disposition_to_issuer","acquired":false,"shares":3668749,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By ABG Acquisition Holdings I LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Class B Shares would have automatically converted into Class A ordinary shares of the Issuer at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, with no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reflects the surrender to the Issuer of 3,668,749 Class B ordinary shares (the \"Class B Shares\") and 501,300 Class A ordinary shares for no consideration by ABG Acquisition Holdings I LLC pursuant to a Share Surrender Letter, dated March 1, 2023, by and between the Issuer and  ABG Acquisition Holdings I LLC."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Class B Shares would have automatically converted into Class A ordinary shares of the Issuer at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, with no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Class B Shares would have automatically converted into Class A ordinary shares of the Issuer at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, with no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"ABG Acquisition Holdings I LLC is the record holder of the shares reported herein. Fan Yu and Andrew Chee On Pang are the managers of  ABG Acquisition Holdings I LLC and together have voting and investment discretion with respect to the ordinary shares held of record by  ABG Acquisition Holdings I LLC. Mr. Yu has sole discretion with respect to the appointment and replacement of managers."}],"balance_after":1,"derivative":{"underlying":"Class A ordinary shares","underlying_shares":3668749},"source":{"system":"sec-edgar","filing":"0000899243-23-006942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668029/000089924323006942/doc4.xml","form_type":"4"}},{"id":1973547,"issuer":{"id":115963,"kind":"organization","name":"ABG Acquisition Corp. I","symbol":"ABGI"},"owners":[{"id":67587,"kind":"person","name":"Yu Fan","position":1,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A ordinary shares","published_at":"2023-03-03T21:00:27.000Z","date":"2023-03-01","kind":"disposition_to_issuer","acquired":false,"shares":501300,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By ABG Acquisition Holdings I LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reflects the surrender to the Issuer of 3,668,749 Class B ordinary shares (the \"Class B Shares\") and 501,300 Class A ordinary shares for no consideration by ABG Acquisition Holdings I LLC pursuant to a Share Surrender Letter, dated March 1, 2023, by and between the Issuer and  ABG Acquisition Holdings I LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"ABG Acquisition Holdings I LLC is the record holder of the shares reported herein. Fan Yu and Andrew Chee On Pang are the managers of  ABG Acquisition Holdings I LLC and together have voting and investment discretion with respect to the ordinary shares held of record by  ABG Acquisition Holdings I LLC. Mr. Yu has sole discretion with respect to the appointment and replacement of managers."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-006942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668029/000089924323006942/doc4.xml","form_type":"4"}},{"id":2302652,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2022-04-06T16:30:30.000Z","date":"2022-04-04","kind":"purchase","acquired":true,"shares":1487058,"price":1.0625,"value":1579999.125,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC, which manages MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership.\n\nAs a result of an internal reorganization, Ally Bridge MedAlpha Management L.P. and Ally Bridge MedAlpha Management GP, LLC are no longer deemed to share beneficial ownership of the securities reported herein."}],"balance_after":1487058,"derivative":{"exercise_price":1.25,"exercise_date":"2022-04-04","expiration_date":"2027-04-04","underlying":"Common Stock","underlying_shares":1487058},"source":{"system":"sec-edgar","filing":"0000899243-22-014088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924322014088/doc4.xml","form_type":"4"}},{"id":2302651,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2022-04-06T16:30:30.000Z","date":"2022-04-04","kind":"purchase","acquired":true,"shares":5571764,"price":1.0625,"value":5919999.25,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":5571764,"derivative":{"exercise_price":1.25,"exercise_date":"2022-04-04","expiration_date":"2027-04-04","underlying":"Common Stock","underlying_shares":5571764},"source":{"system":"sec-edgar","filing":"0000899243-22-014088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924322014088/doc4.xml","form_type":"4"}},{"id":2302650,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T16:30:30.000Z","date":"2022-04-04","kind":"purchase","acquired":true,"shares":2974117,"price":1.0625,"value":3159999.3125,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC, which manages MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership.\n\nAs a result of an internal reorganization, Ally Bridge MedAlpha Management L.P. and Ally Bridge MedAlpha Management GP, LLC are no longer deemed to share beneficial ownership of the securities reported herein."}],"balance_after":5894897,"source":{"system":"sec-edgar","filing":"0000899243-22-014088","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924322014088/doc4.xml","form_type":"4"}},{"id":2302649,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T16:30:30.000Z","date":"2022-04-04","kind":"purchase","acquired":true,"shares":11143529,"price":1.0625,"value":11839999.5625,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":15029480,"source":{"system":"sec-edgar","filing":"0000899243-22-014088","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924322014088/doc4.xml","form_type":"4"}},{"id":2571975,"issuer":{"id":115963,"kind":"organization","name":"ABG Acquisition Corp. I","symbol":"ABGI"},"owners":[{"id":67587,"kind":"person","name":"Yu Fan","position":1,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A ordinary shares","published_at":"2021-09-14T01:14:44.000Z","date":"2021-02-19","kind":"other","acquired":true,"shares":39300,"price":10,"value":393000.0,"ownership":{"direct":false,"nature":"By ABG Acquisition Holdings I LLC"},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The reporting person did not previously report this transaction due to an administrative oversight."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported Class A ordinary shares were purchased as Private Placement Shares by ABG Acquisition Holdings I LLC for $10.00 per share, as described in the Issuer's registration statement on Form S-1 (File No. 333-252621)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"ABG Acquisition Holdings I LLC is the record holder of the shares reported herein. Fan Yu and Andrew Chee On Pang are the managers of ABG Acquisition Holdings I LLC and together have voting and investment discretion with respect to the ordinary shares held of record by ABG Acquisition Holdings I LLC. Mr. Yu has sole discretion with respect to the appointment and replacement of managers."}],"balance_after":501300,"source":{"system":"sec-edgar","filing":"0000899243-21-035745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668029/000089924321035745/doc4.xml","form_type":"4"}},{"id":2921422,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T16:31:34.000Z","date":"2020-12-31","kind":"purchase","acquired":true,"shares":5727,"price":14.9959,"value":85881.5193,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.83 to $15.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2920780,"source":{"system":"sec-edgar","filing":"0000899243-21-000379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924321000379/doc4.xml","form_type":"4"}},{"id":2921421,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T16:31:34.000Z","date":"2020-12-31","kind":"purchase","acquired":true,"shares":6943,"price":14.9959,"value":104116.5337,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.83 to $15.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3885951,"source":{"system":"sec-edgar","filing":"0000899243-21-000379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924321000379/doc4.xml","form_type":"4"}},{"id":2929005,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-30T16:30:17.000Z","date":"2020-12-29","kind":"purchase","acquired":true,"shares":45,"price":14,"value":630.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2915053,"source":{"system":"sec-edgar","filing":"0000899243-20-035506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035506/doc4.xml","form_type":"4"}},{"id":2929004,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-30T16:30:17.000Z","date":"2020-12-29","kind":"purchase","acquired":true,"shares":55,"price":14,"value":770.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3879008,"source":{"system":"sec-edgar","filing":"0000899243-20-035506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035506/doc4.xml","form_type":"4"}},{"id":2929003,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-30T16:30:17.000Z","date":"2020-12-28","kind":"purchase","acquired":true,"shares":3213,"price":13.9766,"value":44906.8158,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.85 to $14.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2915008,"source":{"system":"sec-edgar","filing":"0000899243-20-035506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035506/doc4.xml","form_type":"4"}},{"id":2929002,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-30T16:30:17.000Z","date":"2020-12-28","kind":"purchase","acquired":true,"shares":3894,"price":13.9766,"value":54424.8804,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.85 to $14.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3878953,"source":{"system":"sec-edgar","filing":"0000899243-20-035506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035506/doc4.xml","form_type":"4"}},{"id":2931547,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:30:26.000Z","date":"2020-12-24","kind":"purchase","acquired":true,"shares":4019,"price":13.9919,"value":56233.4461,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.90 to $14.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2911795,"source":{"system":"sec-edgar","filing":"0000899243-20-035198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035198/doc4.xml","form_type":"4"}},{"id":2931546,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:30:26.000Z","date":"2020-12-24","kind":"purchase","acquired":true,"shares":4871,"price":13.9919,"value":68154.5449,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.90 to $14.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3875059,"source":{"system":"sec-edgar","filing":"0000899243-20-035198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035198/doc4.xml","form_type":"4"}},{"id":2931545,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:30:26.000Z","date":"2020-12-23","kind":"purchase","acquired":true,"shares":9810,"price":13.9865,"value":137207.565,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.91 to $14.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2907776,"source":{"system":"sec-edgar","filing":"0000899243-20-035198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035198/doc4.xml","form_type":"4"}},{"id":2931544,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:30:26.000Z","date":"2020-12-23","kind":"purchase","acquired":true,"shares":11890,"price":13.9865,"value":166299.485,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.91 to $14.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3870188,"source":{"system":"sec-edgar","filing":"0000899243-20-035198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035198/doc4.xml","form_type":"4"}},{"id":2931543,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:30:26.000Z","date":"2020-12-22","kind":"purchase","acquired":true,"shares":7661,"price":13.7016,"value":104967.9576,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.45 to $13.96. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2897966,"source":{"system":"sec-edgar","filing":"0000899243-20-035198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035198/doc4.xml","form_type":"4"}},{"id":2931542,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:30:26.000Z","date":"2020-12-22","kind":"purchase","acquired":true,"shares":9287,"price":13.7016,"value":127246.7592,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.45 to $13.96. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3858298,"source":{"system":"sec-edgar","filing":"0000899243-20-035198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035198/doc4.xml","form_type":"4"}},{"id":2934961,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-22T16:30:55.000Z","date":"2020-12-21","kind":"purchase","acquired":true,"shares":7358,"price":13.3147,"value":97969.5626,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.69. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2890305,"source":{"system":"sec-edgar","filing":"0000899243-20-034836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034836/doc4.xml","form_type":"4"}},{"id":2934960,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-22T16:30:55.000Z","date":"2020-12-21","kind":"purchase","acquired":true,"shares":8919,"price":13.3147,"value":118753.8093,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.69. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3849011,"source":{"system":"sec-edgar","filing":"0000899243-20-034836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034836/doc4.xml","form_type":"4"}},{"id":2934959,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-22T16:30:55.000Z","date":"2020-12-18","kind":"purchase","acquired":true,"shares":8408,"price":13.5946,"value":114303.3968,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.38 to $13.84. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2882947,"source":{"system":"sec-edgar","filing":"0000899243-20-034836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034836/doc4.xml","form_type":"4"}},{"id":2934958,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-22T16:30:55.000Z","date":"2020-12-18","kind":"purchase","acquired":true,"shares":10192,"price":13.5946,"value":138556.1632,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.38 to $13.84. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3840092,"source":{"system":"sec-edgar","filing":"0000899243-20-034836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034836/doc4.xml","form_type":"4"}},{"id":2938127,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T16:30:10.000Z","date":"2020-12-17","kind":"purchase","acquired":true,"shares":1029,"price":14,"value":14406.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2874539,"source":{"system":"sec-edgar","filing":"0000899243-20-034482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034482/doc4.xml","form_type":"4"}},{"id":2938126,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T16:30:10.000Z","date":"2020-12-17","kind":"purchase","acquired":true,"shares":1248,"price":14,"value":17472.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3829900,"source":{"system":"sec-edgar","filing":"0000899243-20-034482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034482/doc4.xml","form_type":"4"}},{"id":2938125,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T16:30:10.000Z","date":"2020-12-17","kind":"purchase","acquired":true,"shares":5731,"price":13.1201,"value":75191.2931,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.99 to $13.99. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2873510,"source":{"system":"sec-edgar","filing":"0000899243-20-034482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034482/doc4.xml","form_type":"4"}},{"id":2938124,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T16:30:10.000Z","date":"2020-12-17","kind":"purchase","acquired":true,"shares":6946,"price":13.1201,"value":91132.2146,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.99 to $13.99. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3828652,"source":{"system":"sec-edgar","filing":"0000899243-20-034482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034482/doc4.xml","form_type":"4"}},{"id":2938123,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T16:30:10.000Z","date":"2020-12-16","kind":"purchase","acquired":true,"shares":12851,"price":13.0611,"value":167848.1961,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.20. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2867779,"source":{"system":"sec-edgar","filing":"0000899243-20-034482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034482/doc4.xml","form_type":"4"}},{"id":2938122,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T16:30:10.000Z","date":"2020-12-16","kind":"purchase","acquired":true,"shares":15578,"price":13.0611,"value":203465.8158,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.20. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3821706,"source":{"system":"sec-edgar","filing":"0000899243-20-034482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034482/doc4.xml","form_type":"4"}},{"id":2942885,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T21:00:08.000Z","date":"2020-12-15","kind":"purchase","acquired":true,"shares":9027,"price":13.0821,"value":118092.1167,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.38. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2854928,"source":{"system":"sec-edgar","filing":"0000899243-20-034209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034209/doc4.xml","form_type":"4"}},{"id":2942884,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T21:00:08.000Z","date":"2020-12-15","kind":"purchase","acquired":true,"shares":10942,"price":13.0821,"value":143144.3382,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.38. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3806128,"source":{"system":"sec-edgar","filing":"0000899243-20-034209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034209/doc4.xml","form_type":"4"}},{"id":2942883,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T21:00:08.000Z","date":"2020-12-15","kind":"purchase","acquired":true,"shares":4276,"price":12.4955,"value":53430.758,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.29 to $12.995. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2845901,"source":{"system":"sec-edgar","filing":"0000899243-20-034209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034209/doc4.xml","form_type":"4"}},{"id":2942882,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T21:00:08.000Z","date":"2020-12-15","kind":"purchase","acquired":true,"shares":5184,"price":12.4955,"value":64776.672,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.29 to $12.995. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3795186,"source":{"system":"sec-edgar","filing":"0000899243-20-034209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034209/doc4.xml","form_type":"4"}},{"id":2942881,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T21:00:08.000Z","date":"2020-12-14","kind":"purchase","acquired":true,"shares":6535,"price":12.2443,"value":80016.5005,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.0125 to $12.62. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2841625,"source":{"system":"sec-edgar","filing":"0000899243-20-034209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034209/doc4.xml","form_type":"4"}},{"id":2942880,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T21:00:08.000Z","date":"2020-12-14","kind":"purchase","acquired":true,"shares":7922,"price":12.2443,"value":96999.3446,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.0125 to $12.62. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3790002,"source":{"system":"sec-edgar","filing":"0000899243-20-034209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034209/doc4.xml","form_type":"4"}},{"id":3816485,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":2,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":3,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":4,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":5,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":6,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":7,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":8,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":9,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":10,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-14T16:12:49.000Z","date":"2018-09-13","kind":"sale","acquired":false,"shares":78677,"price":4.9159,"value":386768.2643,"ownership":{"direct":false,"nature":"Through ABG II-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement. Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"ABG II-SO directly owns 1,013,020 shares of common stock of the Issuer. The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Capital Partners II, L.P., as parent of ABG II-SO, (ii) ABG Management Ltd., as manager of Ally Bridge Group Capital Partners II, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1013020,"source":{"system":"sec-edgar","filing":"0001209191-18-051069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919118051069/doc4.xml","form_type":"4"}},{"id":3816484,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":2,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":3,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":4,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":5,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":6,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":7,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":8,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":9,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":10,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-14T16:12:49.000Z","date":"2018-09-13","kind":"sale","acquired":false,"shares":29137,"price":5.0059,"value":145856.9083,"ownership":{"direct":false,"nature":"Through ABG II-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement. Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"ABG II-SO directly owns 1,013,020 shares of common stock of the Issuer. The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Capital Partners II, L.P., as parent of ABG II-SO, (ii) ABG Management Ltd., as manager of Ally Bridge Group Capital Partners II, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1091697,"source":{"system":"sec-edgar","filing":"0001209191-18-051069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919118051069/doc4.xml","form_type":"4"}},{"id":3816483,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":2,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":3,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":4,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":5,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":6,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":7,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":8,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":9,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":10,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-14T16:12:49.000Z","date":"2018-09-12","kind":"sale","acquired":false,"shares":189754,"price":5.0597,"value":960098.3138,"ownership":{"direct":false,"nature":"Through ABG II-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement. Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"ABG II-SO directly owns 1,013,020 shares of common stock of the Issuer. The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Capital Partners II, L.P., as parent of ABG II-SO, (ii) ABG Management Ltd., as manager of Ally Bridge Group Capital Partners II, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1120834,"source":{"system":"sec-edgar","filing":"0001209191-18-051069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919118051069/doc4.xml","form_type":"4"}},{"id":4071146,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-08T08:17:37.000Z","date":"2018-02-07","kind":"sale","acquired":false,"shares":150000,"price":7.1865,"value":1077975.0,"ownership":{"direct":false,"nature":"Through Ally Bridge LB Healthcare Master Fund Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ABG LB directly owns (i) 1,328,529 shares of common stock of the Issuer and (ii) warrants to purchase 432,432 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge LB Management Limited, as manager of ABG LB, (ii) Mr. Fan Yu, as a shareholder and director of Ally Bridge LB Management Limited, and (iii) Mr. Bin Li, as a shareholder and director of Ally Bridge LB Management Limited."}],"balance_after":1328529,"source":{"system":"sec-edgar","filing":"0001209191-18-008299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919118008299/doc4.xml","form_type":"4"}},{"id":4071145,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-08T08:17:37.000Z","date":"2018-02-06","kind":"sale","acquired":false,"shares":512912,"price":6.7541,"value":3464258.9392,"ownership":{"direct":false,"nature":"Through Ally Bridge LB Healthcare Master Fund Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ABG LB directly owns (i) 1,328,529 shares of common stock of the Issuer and (ii) warrants to purchase 432,432 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge LB Management Limited, as manager of ABG LB, (ii) Mr. Fan Yu, as a shareholder and director of Ally Bridge LB Management Limited, and (iii) Mr. Bin Li, as a shareholder and director of Ally Bridge LB Management Limited."}],"balance_after":1478529,"source":{"system":"sec-edgar","filing":"0001209191-18-008299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919118008299/doc4.xml","form_type":"4"}},{"id":4073001,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-07T08:35:48.000Z","date":"2018-02-05","kind":"sale","acquired":false,"shares":16973,"price":8.0038,"value":135848.4974,"ownership":{"direct":false,"nature":"Through ABG Innovation-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Ally Bridge Group Innovation Capital Partners III, L.P. is the owner of the sole voting share of ABG Innovation-SO Limited, which directly owns 1,408,027 shares of common stock of the Issuer. The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Innovation Capital Partners III, L.P., (ii) ABG Management Ltd., as manager of Ally Bridge Group Innovation Capital Partners III, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1408027,"source":{"system":"sec-edgar","filing":"0001209191-18-008030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919118008030/doc4.xml","form_type":"4"}},{"id":4073000,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-07T08:35:48.000Z","date":"2018-02-05","kind":"sale","acquired":false,"shares":37483,"price":8.0038,"value":300006.4354,"ownership":{"direct":false,"nature":"Through ABG SRNE Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"ABG SRNE directly owns (i) 3,041,759 shares of common stock of the Issuer and (ii) warrants to purchase 972,972 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Innovation Capital Partners III, L.P., as owner of the sole voting share of ABG SRNE, (ii) ABG Management Ltd., as manager of Ally Bridge Group Innovation Capital Partners III, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":3041759,"source":{"system":"sec-edgar","filing":"0001209191-18-008030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919118008030/doc4.xml","form_type":"4"}},{"id":4072999,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-07T08:35:48.000Z","date":"2018-02-05","kind":"sale","acquired":false,"shares":16265,"price":8.0038,"value":130181.807,"ownership":{"direct":false,"nature":"Through ABG II-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"ABG II-SO directly owns 1,310,588 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Capital Partners II, L.P., as parent of ABG II-SO, (ii) ABG Management Ltd., as manager of Ally Bridge Group Capital Partners II, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1310588,"source":{"system":"sec-edgar","filing":"0001209191-18-008030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919118008030/doc4.xml","form_type":"4"}},{"id":4084008,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-31T09:09:36.000Z","date":"2018-01-30","kind":"sale","acquired":false,"shares":57037,"price":7.6527,"value":436487.0499,"ownership":{"direct":false,"nature":"Through ABG Innovation-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Ally Bridge Group Innovation Capital Partners III, L.P. is the owner of the sole voting share of ABG Innovation-SO Limited, which directly owns 1,425,000 shares of common stock of the Issuer. The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Innovation Capital Partners III, L.P., (ii) ABG Management Ltd., as manager of Ally Bridge Group Innovation Capital Partners III, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1425000,"source":{"system":"sec-edgar","filing":"0001104659-18-005307","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465918005307/a4.xml","form_type":"4"}},{"id":4084007,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-31T09:09:36.000Z","date":"2018-01-29","kind":"sale","acquired":false,"shares":17963,"price":7.6063,"value":136631.9669,"ownership":{"direct":false,"nature":"Through ABG Innovation-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Ally Bridge Group Innovation Capital Partners III, L.P. is the owner of the sole voting share of ABG Innovation-SO Limited, which directly owns 1,425,000 shares of common stock of the Issuer. The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Innovation Capital Partners III, L.P., (ii) ABG Management Ltd., as manager of Ally Bridge Group Innovation Capital Partners III, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1482037,"source":{"system":"sec-edgar","filing":"0001104659-18-005307","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465918005307/a4.xml","form_type":"4"}},{"id":4084006,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-31T09:09:36.000Z","date":"2018-01-30","kind":"sale","acquired":false,"shares":124333,"price":7.6527,"value":951483.1491,"ownership":{"direct":false,"nature":"Through ABG SRNE Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"ABG SRNE directly owns (i) 3,079,242 shares of common stock of the Issuer and (ii) warrants to purchase 972,972 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Innovation Capital Partners III, L.P., as owner of the sole voting share of ABG SRNE, (ii) ABG Management Ltd., as manager of Ally Bridge Group Innovation Capital Partners III, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":3079242,"source":{"system":"sec-edgar","filing":"0001104659-18-005307","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465918005307/a4.xml","form_type":"4"}},{"id":4084005,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-31T09:09:36.000Z","date":"2018-01-29","kind":"sale","acquired":false,"shares":39667,"price":7.6063,"value":301719.1021,"ownership":{"direct":false,"nature":"Through ABG SRNE Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"ABG SRNE directly owns (i) 3,079,242 shares of common stock of the Issuer and (ii) warrants to purchase 972,972 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Innovation Capital Partners III, L.P., as owner of the sole voting share of ABG SRNE, (ii) ABG Management Ltd., as manager of Ally Bridge Group Innovation Capital Partners III, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":3203575,"source":{"system":"sec-edgar","filing":"0001104659-18-005307","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465918005307/a4.xml","form_type":"4"}},{"id":4084004,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-31T09:09:36.000Z","date":"2018-01-30","kind":"sale","acquired":false,"shares":53786,"price":7.6527,"value":411608.1222,"ownership":{"direct":false,"nature":"Through ABG II-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"ABG II-SO directly owns 1,326,853 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Capital Partners II, L.P., as parent of ABG II-SO, (ii) ABG Management Ltd., as manager of Ally Bridge Group Capital Partners II, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1326853,"source":{"system":"sec-edgar","filing":"0001104659-18-005307","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465918005307/a4.xml","form_type":"4"}},{"id":4084003,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163634,"kind":"organization","name":"ABG Innovation-SO Ltd","position":8,"cik":"0001704525","reported_name":"ABG Innovation-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":10,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-31T09:09:36.000Z","date":"2018-01-29","kind":"sale","acquired":false,"shares":17214,"price":7.6063,"value":130934.8482,"ownership":{"direct":false,"nature":"Through ABG II-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited, a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"ABG II-SO directly owns 1,326,853 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Capital Partners II, L.P., as parent of ABG II-SO, (ii) ABG Management Ltd., as manager of Ally Bridge Group Capital Partners II, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1380639,"source":{"system":"sec-edgar","filing":"0001104659-18-005307","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465918005307/a4.xml","form_type":"4"}},{"id":4348140,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":8,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":9,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-21T07:16:46.000Z","date":"2017-04-19","kind":"purchase","acquired":true,"shares":550000,"price":2,"value":1100000.0,"ownership":{"direct":false,"nature":"Through Ally Bridge LB Healthcare Master Fund Limited See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (ix) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"ABG LB directly owns (i) 1,991,441 shares of common stock of the Issuer and (ii) warrants to purchase 432,432 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge LB Management Limited, as manager of ABG LB, (ii) Mr. Fan Yu, as a shareholder and director of Ally Bridge LB Management Limited, and (iii) Mr. Bin Li, as a shareholder and director of Ally Bridge LB Management Limited."}],"balance_after":1991441,"source":{"system":"sec-edgar","filing":"0001104659-17-025040","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465917025040/a4.xml","form_type":"4"}},{"id":4351791,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":8,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-17T21:59:42.000Z","date":"2017-04-13","kind":"purchase","acquired":true,"shares":1500000,"price":2,"value":3000000.0,"ownership":{"direct":false,"nature":"Through ABG Innovation-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited (\"ABG Innovation\"), a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"ABG Innovation directly owns 1,500,000 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Innovation Capital Partners III, L.P., as owner of the sole voting share of ABG Innovation, (ii) ABG Management Ltd., as manager of Ally Bridge Group Innovation Capital Partners III, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1500000,"source":{"system":"sec-edgar","filing":"0001104659-17-023841","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465917023841/a4.xml","form_type":"4"}},{"id":4351790,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":8,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":9,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-17T21:59:42.000Z","date":"2017-04-13","kind":"purchase","acquired":true,"shares":1000000,"price":2,"value":2000000.0,"ownership":{"direct":false,"nature":"Through ABG II-SO Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) ABG Innovation-SO Limited (\"ABG Innovation\"), a British Virgin Islands limited company,"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(ix) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (x) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"ABG II-SO directly owns 1,397,853 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Capital Partners II, L.P., as parent of ABG II-SO, (ii) ABG Management Ltd., as manager of Ally Bridge Group Capital Partners II, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":1397853,"source":{"system":"sec-edgar","filing":"0001104659-17-023841","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465917023841/a4.xml","form_type":"4"}},{"id":4480773,"issuer":{"id":112149,"kind":"organization","name":"BIOCEPT INC","symbol":"BIOC"},"owners":[{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":1,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":2,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":3,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":4,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-26T06:05:24.000Z","date":"2017-01-19","kind":"disposition_to_issuer","acquired":false,"shares":254893,"price":1.1,"value":280382.3,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Ally Bridge LB Healthcare Master Fund Limited (the \"Master Fund\") directly held the disposed Common Stock and currently holds warrants to purchase 1,681,000 shares of Common Stock..  Ally Bridge LB Management Limited (\"LB Management\") owns the sole voting share of the Master Fund. Mr. Fan Yu and Mr. Bin Li are the shareholders and directors of LB Management. LB Management, by virtue of it being the holder of the sole voting share of the Master Fund, and each of Mr. Yu and Mr. Li, by virtue of being a shareholder and director of LB Management, may be deemed to have voting control and investment discretion over any shares held by the Master Fund. Each of LB Management, Mr. Yu and Mr. Li disclaims beneficial ownership of such securities, except to the extent of their pecuniary interest therein, if any."},{"field":"security","element":"securityTitle","label":"F2","text":"(continued from footnote 1) This Form 4 shall not be deemed an admission that any of them are the beneficial owners of, or have any pecuniary interest in, such securities for any purposes. By virtue of the transactions described in that certain statement on Schedule 13D/A filed in January 2017, by the Reporting Persons, pursuant to Section 13(d)(3) of the Securities Exchange Act of 1934 (the \"Exchange Act\"), the Reporting Persons may, based on facts described elsewhere in the Schedule 13D, be considered to be a \"group\";  however,  neither the filing of this Form 4 nor any of its contents shall be deemed to constitute an admission by such persons that such a group exists."},{"field":"security","element":"securityTitle","label":"F3","text":"All 1,681,000 shares of Common Stock held by the Master Fund were disposed in a series of sales of the Common Stock on January 17, 2017, January 18, 2017 and January 19, 2017.  The Master Fund still holds warrants to purchase 1,681,000 shares of Common Stock.  The warrants held by the Master Fund represent 8.76% of the Common Stock, calculated based on 19,180,397 shares of Commons Stock, which is the total of (i) 17,499,397 shares of the Issuer's Common Stock outstanding as of November 4, 2016, as reported in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2016 filed with the SEC on November 10, 2016; and (ii) 1,681,000 shares of Common Stock issuable upon exercise of warrants held by the Master Fund."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-17-001973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1044378/000089924317001973/doc4.xml","form_type":"4"}},{"id":4480772,"issuer":{"id":112149,"kind":"organization","name":"BIOCEPT INC","symbol":"BIOC"},"owners":[{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":1,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":2,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":3,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":4,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-26T06:05:24.000Z","date":"2017-01-18","kind":"disposition_to_issuer","acquired":false,"shares":549708,"price":1.1,"value":604678.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Ally Bridge LB Healthcare Master Fund Limited (the \"Master Fund\") directly held the disposed Common Stock and currently holds warrants to purchase 1,681,000 shares of Common Stock..  Ally Bridge LB Management Limited (\"LB Management\") owns the sole voting share of the Master Fund. Mr. Fan Yu and Mr. Bin Li are the shareholders and directors of LB Management. LB Management, by virtue of it being the holder of the sole voting share of the Master Fund, and each of Mr. Yu and Mr. Li, by virtue of being a shareholder and director of LB Management, may be deemed to have voting control and investment discretion over any shares held by the Master Fund. Each of LB Management, Mr. Yu and Mr. Li disclaims beneficial ownership of such securities, except to the extent of their pecuniary interest therein, if any."},{"field":"security","element":"securityTitle","label":"F2","text":"(continued from footnote 1) This Form 4 shall not be deemed an admission that any of them are the beneficial owners of, or have any pecuniary interest in, such securities for any purposes. By virtue of the transactions described in that certain statement on Schedule 13D/A filed in January 2017, by the Reporting Persons, pursuant to Section 13(d)(3) of the Securities Exchange Act of 1934 (the \"Exchange Act\"), the Reporting Persons may, based on facts described elsewhere in the Schedule 13D, be considered to be a \"group\";  however,  neither the filing of this Form 4 nor any of its contents shall be deemed to constitute an admission by such persons that such a group exists."},{"field":"security","element":"securityTitle","label":"F3","text":"All 1,681,000 shares of Common Stock held by the Master Fund were disposed in a series of sales of the Common Stock on January 17, 2017, January 18, 2017 and January 19, 2017.  The Master Fund still holds warrants to purchase 1,681,000 shares of Common Stock.  The warrants held by the Master Fund represent 8.76% of the Common Stock, calculated based on 19,180,397 shares of Commons Stock, which is the total of (i) 17,499,397 shares of the Issuer's Common Stock outstanding as of November 4, 2016, as reported in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2016 filed with the SEC on November 10, 2016; and (ii) 1,681,000 shares of Common Stock issuable upon exercise of warrants held by the Master Fund."}],"balance_after":254893,"source":{"system":"sec-edgar","filing":"0000899243-17-001973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1044378/000089924317001973/doc4.xml","form_type":"4"}},{"id":4480771,"issuer":{"id":112149,"kind":"organization","name":"BIOCEPT INC","symbol":"BIOC"},"owners":[{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":1,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":2,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":3,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":4,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-26T06:05:24.000Z","date":"2017-01-17","kind":"disposition_to_issuer","acquired":false,"shares":876399,"price":1.1,"value":964038.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Ally Bridge LB Healthcare Master Fund Limited (the \"Master Fund\") directly held the disposed Common Stock and currently holds warrants to purchase 1,681,000 shares of Common Stock..  Ally Bridge LB Management Limited (\"LB Management\") owns the sole voting share of the Master Fund. Mr. Fan Yu and Mr. Bin Li are the shareholders and directors of LB Management. LB Management, by virtue of it being the holder of the sole voting share of the Master Fund, and each of Mr. Yu and Mr. Li, by virtue of being a shareholder and director of LB Management, may be deemed to have voting control and investment discretion over any shares held by the Master Fund. Each of LB Management, Mr. Yu and Mr. Li disclaims beneficial ownership of such securities, except to the extent of their pecuniary interest therein, if any."},{"field":"security","element":"securityTitle","label":"F2","text":"(continued from footnote 1) This Form 4 shall not be deemed an admission that any of them are the beneficial owners of, or have any pecuniary interest in, such securities for any purposes. By virtue of the transactions described in that certain statement on Schedule 13D/A filed in January 2017, by the Reporting Persons, pursuant to Section 13(d)(3) of the Securities Exchange Act of 1934 (the \"Exchange Act\"), the Reporting Persons may, based on facts described elsewhere in the Schedule 13D, be considered to be a \"group\";  however,  neither the filing of this Form 4 nor any of its contents shall be deemed to constitute an admission by such persons that such a group exists."},{"field":"security","element":"securityTitle","label":"F3","text":"All 1,681,000 shares of Common Stock held by the Master Fund were disposed in a series of sales of the Common Stock on January 17, 2017, January 18, 2017 and January 19, 2017.  The Master Fund still holds warrants to purchase 1,681,000 shares of Common Stock.  The warrants held by the Master Fund represent 8.76% of the Common Stock, calculated based on 19,180,397 shares of Commons Stock, which is the total of (i) 17,499,397 shares of the Issuer's Common Stock outstanding as of November 4, 2016, as reported in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2016 filed with the SEC on November 10, 2016; and (ii) 1,681,000 shares of Common Stock issuable upon exercise of warrants held by the Master Fund."}],"balance_after":804601,"source":{"system":"sec-edgar","filing":"0000899243-17-001973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1044378/000089924317001973/doc4.xml","form_type":"4"}},{"id":4495590,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":8,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":9,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-09T08:33:28.000Z","date":"2017-01-05","kind":"other","acquired":true,"shares":3243242,"ownership":{"direct":false,"nature":"Through ABG SRNE Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\").  According to a Form 8-K filing by the Issuer on January 5, 2017, the Issuer consummated a transaction that involved (i) the cancellation of warrants to purchase an aggregate of 1,137,316 shares of Common Stock (the \"Warrants\") and cancellation of secured promissory notes in an aggregate principal amount of $53,502,315 that were issued to the Issuer, of which $43,502,315 in aggregate principal amount was outstanding as of December 31, 2016 (the \"Notes\") and (ii) forfeiture of 7,838,259 shares of Common Stock (the \"Shares\") which were returned to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Prior to the forfeiture of the Shares and the cancellation of the Warrants and Notes, the Issuer had 58,721,115 Shares outstanding and warrants to purchase an aggregate of 7,070,314 shares of Common Stock outstanding.  The Issuer now has 50,882,856 Shares outstanding and warrants to purchase an aggregate of 5,932,998 shares of Common Stock outstanding.  As a result of this transaction, the Reporting Persons' (defined below) collective ownership of the Issuer's securities have increased."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (ix) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"ABG SRNE directly owns (i) 3,243,242 shares of common stock of the Issuer and (ii) warrants to purchase 972,972 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Innovation Capital Partners III, L.P., as owner of the sole voting share of ABG SRNE, (ii) ABG Management Ltd., as manager of Ally Bridge Group Innovation Capital Partners III, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":3243242,"source":{"system":"sec-edgar","filing":"0001104659-17-001383","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465917001383/a4.xml","form_type":"4"}},{"id":4495589,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":8,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":9,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-09T08:33:28.000Z","date":"2017-01-05","kind":"other","acquired":true,"shares":1441441,"ownership":{"direct":false,"nature":"Through Ally Bridge LB Healthcare Master Fund Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\").  According to a Form 8-K filing by the Issuer on January 5, 2017, the Issuer consummated a transaction that involved (i) the cancellation of warrants to purchase an aggregate of 1,137,316 shares of Common Stock (the \"Warrants\") and cancellation of secured promissory notes in an aggregate principal amount of $53,502,315 that were issued to the Issuer, of which $43,502,315 in aggregate principal amount was outstanding as of December 31, 2016 (the \"Notes\") and (ii) forfeiture of 7,838,259 shares of Common Stock (the \"Shares\") which were returned to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Prior to the forfeiture of the Shares and the cancellation of the Warrants and Notes, the Issuer had 58,721,115 Shares outstanding and warrants to purchase an aggregate of 7,070,314 shares of Common Stock outstanding.  The Issuer now has 50,882,856 Shares outstanding and warrants to purchase an aggregate of 5,932,998 shares of Common Stock outstanding.  As a result of this transaction, the Reporting Persons' (defined below) collective ownership of the Issuer's securities have increased."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (ix) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ABG LB directly owns (i) 1,441,441 shares of common stock of the Issuer and (ii) warrants to purchase 432,432 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge LB Management Limited, as manager of ABG LB, (ii) Mr. Fan Yu, as a shareholder and director of Ally Bridge LB Management Limited, and (iii) Mr. Bin Li, as a shareholder and director of Ally Bridge LB Management Limited."}],"balance_after":1441441,"source":{"system":"sec-edgar","filing":"0001104659-17-001383","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465917001383/a4.xml","form_type":"4"}},{"id":4495588,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":163632,"kind":"organization","name":"ABG Management Ltd","position":1,"cik":"0001668027","reported_name":"ABG Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163635,"kind":"organization","name":"ABG SRNE Ltd","position":2,"cik":"0001676083","reported_name":"ABG SRNE Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163636,"kind":"organization","name":"Ally Bridge Group Capital Partners II, L.P.","position":3,"cik":"0001609313","reported_name":"Ally Bridge Group Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163633,"kind":"organization","name":"ABG II-SO Ltd","position":4,"cik":"0001676141","reported_name":"ABG II-SO Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163638,"kind":"organization","name":"Ally Bridge LB Healthcare Master Fund Ltd","position":5,"cik":"0001667354","reported_name":"Ally Bridge LB Healthcare Master Fund Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163639,"kind":"organization","name":"Ally Bridge LB Management Ltd","position":6,"cik":"0001668028","reported_name":"Ally Bridge LB Management Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163637,"kind":"organization","name":"Ally Bridge Group Innovation Capital Partners III, L.P.","position":7,"cik":"0001674513","reported_name":"Ally Bridge Group Innovation Capital Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":8,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163640,"kind":"person","name":"Li Bin","position":9,"cik":"0001668219","reported_name":"Li Bin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-09T08:33:28.000Z","date":"2017-01-05","kind":"other","acquired":true,"shares":397853,"ownership":{"direct":false,"nature":"Through ABG II-SO Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Persons are making this joint, single filing because they may be deemed to constitute a \"group\" within the meaning of Section 13(d)(3) of the Securities Exchange Act 1934 as amended (the \"Act\").  According to a Form 8-K filing by the Issuer on January 5, 2017, the Issuer consummated a transaction that involved (i) the cancellation of warrants to purchase an aggregate of 1,137,316 shares of Common Stock (the \"Warrants\") and cancellation of secured promissory notes in an aggregate principal amount of $53,502,315 that were issued to the Issuer, of which $43,502,315 in aggregate principal amount was outstanding as of December 31, 2016 (the \"Notes\") and (ii) forfeiture of 7,838,259 shares of Common Stock (the \"Shares\") which were returned to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Prior to the forfeiture of the Shares and the cancellation of the Warrants and Notes, the Issuer had 58,721,115 Shares outstanding and warrants to purchase an aggregate of 7,070,314 shares of Common Stock outstanding.  The Issuer now has 50,882,856 Shares outstanding and warrants to purchase an aggregate of 5,932,998 shares of Common Stock outstanding.  As a result of this transaction, the Reporting Persons' (defined below) collective ownership of the Issuer's securities have increased."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Form 4 is filed by and on behalf of each of the following persons (each a \"Reporting Person\"): (i) ABG II-SO Limited (\"ABG II-SO\"), a British Virgin Islands limited company, (ii) Ally Bridge Group Capital Partners II, L.P., a Cayman Islands limited partnership, (iii) Ally Bridge LB Healthcare Master Fund Limited (\"ABG LB\"), a Cayman Islands limited company, (iv) Ally Bridge LB Management Limited, a Cayman Islands limited company, (v) ABG SRNE Limited (\"ABG SRNE\"), a British Virgin Islands limited company, (vi) Ally Bridge Group Innovation Capital Partners III, L.P., a Cayman Islands limited company, (vii) ABG Management Ltd., a Cayman Islands limited partnership, (viii) Mr. Fan Yu, a director of ABG LB and a shareholder and director of Ally Bridge LB Management Limited, and the sole shareholder and director of ABG Management Ltd., and (ix) Mr. Bin Li, a director and executive officer of ABG LB and a shareholder and director of Ally Bridge LB Management Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for the purpose of Section 16 of the Act or otherwise, the beneficial owner of any securities covered by this statement.  Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"ABG II-SO directly owns 397,853 shares of common stock of the Issuer.  The following Reporting Persons may be deemed to beneficially own such securities: (i) Ally Bridge Group Capital Partners II, L.P., as parent of ABG II-SO, (ii) ABG Management Ltd., as manager of Ally Bridge Group Capital Partners II, L.P., and (iii) Mr. Fan Yu, as sole shareholder and director of ABG Management Ltd."}],"balance_after":397853,"source":{"system":"sec-edgar","filing":"0001104659-17-001383","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000110465917001383/a4.xml","form_type":"4"}}]}